Literature DB >> 15278494

The effects of an intravenous nicardipine injection on baroreflex control of heart rate in man.

Z Wajima1, T Inoue, R Ogawa.   

Abstract

The effects of nicardipine injection on baroreflex control of heart rate were investigated by both pressor and depressor tests in 17 adult patients. Baroreflex sensitivity was attenuated after nicardipine injection by the pressor test using phenylephrine, whereas it was not changed by the depressor test using nitroglycerine. No resetting of the baroreflex occurred after nicardipine injection. By the pressor test, the plasma norepinephrine level was decreased, indicating that parasympathetic activity increased, and by the depressor test, the plasma norepinephrine concentration was increased, indicating that sympathetic activity increased. These results suggest that it is safe to use nicardipine clinically even when reduction in blood pressure for hypovolemia or unclamping the main artery is expected, and it is disadvantageous to administer the drug when an increase in blood pressure due to cross-clamping of the main artery is forecasted.

Entities:  

Year:  1993        PMID: 15278494     DOI: 10.1007/s0054030070040

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  16 in total

1.  [Endocrine effects of hypotension induced by nicardipine in rabbits].

Authors:  S Takeda; Y Inada; N Tashiro; K Matsui; T Tomaru; H Negishi; A Hosoyamada
Journal:  Masui       Date:  1990-08

2.  Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity.

Authors:  H S Smyth; P Sleight; G W Pickering
Journal:  Circ Res       Date:  1969-01       Impact factor: 17.367

3.  Effects of anesthesia on baroreflex control of heart rate in man.

Authors:  J D Bristow; C Prys-Roberts; A Fisher; T G Pickering; P Sleight
Journal:  Anesthesiology       Date:  1969-11       Impact factor: 7.892

4.  Comparison of calcium channel inhibitors on vagal heart rate responses elicited by arterial baroreceptor reflexes in anesthetized dogs.

Authors:  D G Taylor; T E Kowalski
Journal:  J Pharmacol Exp Ther       Date:  1984-02       Impact factor: 4.030

5.  Attenuation by diltiazem of arterial baroreflex sensitivity in man.

Authors:  J F Giudicelli; A Berdeaux; A Edouard; F Lhoste; C Richer; C Thuillez; A Jacolot
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  [A comparison of the endocrine effects of hypotension induced by nicardipine with those by sodium nitroprusside in dogs].

Authors:  S Takeda; Y Inada; N Nakamizo; N Nomura; T Tomaru; H Negishi; A Hosoyamada
Journal:  Masui       Date:  1991-07

7.  Effects of calcium channel blockers on isolated carotid baroreceptors and baroreflex.

Authors:  C M Heesch; B M Miller; M D Thames; F M Abboud
Journal:  Am J Physiol       Date:  1983-10

8.  Influence of nifedipine on arterial baroreflex modulation of heart rate control during dynamic increases in arterial pressure: studies in normal man.

Authors:  D W Ferguson
Journal:  Am Heart J       Date:  1987-10       Impact factor: 4.749

9.  Effects of droperidol on sympathetic activity and baroreflex control of heart rate in humans.

Authors:  D Balagny; R Gauzit; J Marty; E Couderc; J C Levron; J M Desmonts
Journal:  Anesthesiology       Date:  1987-10       Impact factor: 7.892

10.  Effects of diazepam and midazolam on baroreflex control of heart rate and on sympathetic activity in humans.

Authors:  J Marty; R Gauzit; P Lefevre; E Couderc; R Farinotti; C Henzel; J M Desmonts
Journal:  Anesth Analg       Date:  1986-02       Impact factor: 5.108

View more
  2 in total

1.  Does intravenous landiolol, a β1-adrenergic blocker, affect stroke volume variation?

Authors:  Zen'ichiro Wajima; Toshiya Shiga; Kazuyuki Imanaga; Tetsuo Inoue
Journal:  J Anesth       Date:  2013-05-08       Impact factor: 2.078

2.  The effects of butorphanol on baroreflex control of heart rate in man.

Authors:  Z Wajima; T Inoue; R Ogawa
Journal:  J Anesth       Date:  1993-10       Impact factor: 2.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.